Ocuphire Pharma, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Equipment, Net

Equipment, Net

12 Months Ended

Dec. 31, 2011

7.	Equipment, Net

	December 31,			December 31,
	2011			2010

Furniture and fixtures	$	34,200		$	32,169
Office equipment		81,074			77,032
Lab and computer equipment		430,261			429,415
Leasehold improvements		119,841			110,713

		665,376			649,329
Less Accumulated depreciation		(570,834	)		(525,764	)

Net carrying amount	$	94,542		$	123,565

Depreciation expense was $45,070, $50,659 and $41,604 for the years ended December 31, 2011, 2010 and 2009, respectively.

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details